Trends in utilization of antiepileptic drugs in Denmark

被引:83
作者
Tsiropoulos, I
Gichangi, A
Andersen, M
Bjerrum, L
Gaist, D
Hallas, J
机构
[1] Odense Univ Hosp, Dept Neurol, DK-5000 Odense C, Denmark
[2] Univ So Denmark, Res Unit Clin Pharmacol, Inst Publ Hlth, Odense, Denmark
[3] Univ So Denmark, Dept Stat, Inst Publ Hlth, Odense, Denmark
[4] Univ So Denmark, Res Unit Gen Practice, Inst Publ Hlth, Odense, Denmark
[5] Odense Univ Hosp, Dept Internal Med, DK-5000 Odense C, Denmark
来源
ACTA NEUROLOGICA SCANDINAVICA | 2006年 / 113卷 / 06期
关键词
anticonvulsants; antiepileptic drugs; epilepsy; prescription register; drug utilization;
D O I
10.1111/j.1600-0404.2006.00639.x
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Objectives - To describe utilization of antiepileptic drugs (AEDs) in Denmark during 1993-2002, with special emphasis on oxcarbazepine, and to assess probable indications for AED use. Materials and methods - We retrieved prescription data from Odense University Pharmacoepidemiological Database, in Funen County, Denmark (population in 2002: 472,869). Within each calendar year we estimated period prevalence, incidence rate and monotherapy rate. Based on co-medication we defined 'epilepsy' when only AEDs were prescribed, 'pain' with co-prescription of opioids, and 'mood disorder' with co-prescription of antipsychotics or antidepressants. Results - We identified 15,604 AED users. The prevalence of using AED increased from 9.3 (95% CI, 9-9.5) to 12.1 (11.8-12.4)/1000 persons. The incidence rate increased from 1.4 (1.3-1.6) to 1.7 (1.6-1.9)/1000 personyears. The monotherapy rate was 79-82%. AED use for 'epilepsy' declined by 19.7%, whereas the proportion of 'pain' and 'mood disorder' treatment increased by 11.2% and 8.4% respectively. Conclusions - Antiepileptic drug utilization increased during the study period, the increase probably caused by expanding use in areas other than epilepsy.
引用
收藏
页码:405 / 411
页数:7
相关论文
共 28 条
[11]  
FRIIS ML, 1993, ACTA NEUROL SCAND, V87, P224
[12]  
Gaist D, 1997, DAN MED BULL, V44, P445
[13]   The psychiatric comorbidity of epilepsy [J].
Gaitatzis, A ;
Trimble, MR ;
Sander, JW .
ACTA NEUROLOGICA SCANDINAVICA, 2004, 110 (04) :207-220
[14]  
Gilliam F, 2002, EPILEPSY BEHAV, V3, pS2
[15]  
GIULIANI G, 1992, ACTA NEUROL SCAND, V85, P23
[16]  
HALLAS J, 1994, EUR J CLIN PHARMACOL, V47, P367
[17]   INCIDENCE OF EPILEPSY AND UNPROVOKED SEIZURES IN ROCHESTER, MINNESOTA - 1935-1984 [J].
HAUSER, WA ;
ANNEGERS, JF ;
KURLAND, LT .
EPILEPSIA, 1993, 34 (03) :453-468
[18]   Cancer patients' share in a population's use of opioids. A linkage study between a prescription database and the Danish Cancer Registry [J].
Jarlbaek, L ;
Andersen, M ;
Kragstrup, J ;
Hallas, J .
JOURNAL OF PAIN AND SYMPTOM MANAGEMENT, 2004, 27 (01) :36-43
[19]   Extending indications for long-term pharmacotherapy: Opportunities and challenges [J].
Kane, JM .
AMERICAN JOURNAL OF PSYCHIATRY, 2002, 159 (01) :1-2
[20]   A comparison of divalproex with propranolol and placebo for the prophylaxis of migraine without aura [J].
Kaniecki, RG .
ARCHIVES OF NEUROLOGY, 1997, 54 (09) :1141-1145